Skip to content
2000
Volume 8, Issue 9
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Synthetic steroidal progestins and antiprogestins have been widely used for decades to treat many gynecological conditions. The concept of selective progesterone receptor modulators (SPRMs) has been developed in recent years to design new therapeutic agents that have desirable PR modulating activity with significantly reduced sideeffects or increased safety margin. This review describes medicinal chemistry progress of multiple nonsteroidal SPRM series based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802608784535020
2008-06-01
2025-06-01
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802608784535020
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test